Bio-Techne vs Twist Bioscience
TECH and TWST side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How TECH and TWST compare
Bio-Techne is the larger company, worth 1.2 times as much as Twist Bioscience ($11.4B against $9.6B).
Twist Bioscience grew revenue faster over the last twelve months (19.2% versus −0.38% for Bio-Techne).
Bio-Techne pays a dividend yielding 0.44%; Twist Bioscience does not pay one.
Twist Bioscience scores higher on the StockData Score (13 against 12 for Bio-Techne), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | TECH | TWST |
|---|---|---|
| Size and price | ||
| Market cap | $11.4B | $9.6B |
| Share price | $72.66 | $152.78 |
| Change, 1 year | 17.2% | 374% |
| Change, 5 years | −41.6% | 12.4% |
| Beta (5Y) | 1.08 | 2.28 |
| Employees | 3,000 | 979 |
| StockData Score | ||
| Total score | 12 | 13 (better) |
| Valuation score | 2 (better) | 0 |
| Growth score | 1 | 4 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 6 | 6 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 62.6× | – |
| P/S | 9.4× (better) | 22.2× |
| P/B | 5.4× (better) | 21.5× |
| EV/EBITDA | 32.4× | – |
| P/FCF | 43.3× | – |
| FCF yield | 2.3% (better) | −0.97% |
| Fair value | $52.72 | $34.30 |
| Margin of safety | −37.8% (better) | −345% |
| Growth | ||
| Revenue growth (TTM) | −0.38% | 19.2% (better) |
| Revenue growth, 5Y average | 5.5% | 33.1% (better) |
| EPS growth (TTM) | 152% | – |
| EPS growth, 5Y average | 5.9% | – |
| Profitability | ||
| Gross margin | 65.8% (better) | 52.0% |
| Operating margin | 20.7% (better) | −33.6% |
| Net margin | – | −31.7% |
| FCF margin | 21.7% (better) | −21.6% |
| Return on equity | – | −29.6% |
| Return on invested capital | 9.2% (better) | −45.5% |
| Financial health | ||
| Debt / equity | 0.09 (better) | 0.00 |
| Net debt / EBITDA | −0.19 | – |
| Interest coverage | 26.2× | – |
| Current ratio | 4.55 (better) | 2.67 |
| Altman Z-score | 15.97 | 22.67 (better) |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.44% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 0.37% | – |
| Shareholder yield | 0.81% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 112% | 122% |
| Held by insiders | 0.35% | 2.3% |
| Insider net buying, 12 months | −$437K (better) | −$126M |
| Superinvestors holding | 4 | – |
| Short interest, % of float | 4.7% | 17.3% |
Go deeper
- TECH stock overview
- TECH income statement
- TECH valuation and score
- TWST stock overview
- TWST income statement
- TWST valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.